ACU-6151

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameACU-6151
Drug Alias Namebiomimetic small molecule therapeutic (Eyemedix)biomimetic vascular endothelial growth factor inhibitor (Kubota Vision/EyeMedics)ACU-6151
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeovascularization, Pathologic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEyeMedix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEyeMedics LLCEyeMedix IncKubota Vision Inc
Active IndicationsN/A
Inactive IndicationsNeovascularization, Pathologic

Other Information

ATC CodeN/A
Related LinksN/A